Tyrosine kinase inhibitor resistance in pediatric chronic myeloid leukemia: a case report
Pediatric chronic myeloid leukemia (CML) is a hematopoietic malignancy, treated by tyrosine kinase inhibitor (TKI). Previously, imatinib resistance in CML was treated with nilotinib as a second line. However, in Indonesia, where the options of TKIs are limited, no case has been reported. We describ...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine Universitas Indonesia
2020-10-01
|
| Series: | Medical Journal of Indonesia |
| Subjects: | |
| Online Access: | https://mji.ui.ac.id/journal/index.php/mji/article/view/3765 |